Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Memorial Sloan-Kettering Cancer Center
Sponsor:
Collaborators:
University School of Medicine(VA-NYU)
State University of New York - Downstate Medical Center
Kings County Hospital Center
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00581672
First received: December 21, 2007
Last updated: October 6, 2014
Last verified: October 2014

December 21, 2007
October 6, 2014
January 2010
December 2015   (final data collection date for primary outcome measure)
To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer. [ Time Frame: within one to three weeks of receiving their PSA scores from their physician ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00581672 on ClinicalTrials.gov Archive Site
To explore the prevalence of distress, anxiety, and depression in Black men with prostate cancer. [ Time Frame: within one to three weeks of receiving their PSA scores from their physician ] [ Designated as safety issue: No ]
Not Provided
Not Provided
Not Provided
 
Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men
Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men

This study is being done to see if a standard tool used to check anxiety in white men works well for Black men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If the investigators have a good tool, it is more likely that the investigators can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Black men with prostate cancer

Prostate Cancer
Behavioral: questionnaires of quality of life
Subjects will be asked to complete the MAX-PC along with additional psychosocial questionnaires which include anxiety, depression coping methods, resilience spirituality, religiosity, and quality of life measures and will take approximately one 30 to 45 minutes to complete by patient.
questionnaires
Black men with prostate cancer
Intervention: Behavioral: questionnaires of quality of life
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
200
December 2015
December 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years of age or older
  • Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results
  • Diagnosis of prostate cancer
  • Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic).
  • Ability to comprehend and complete questionnaires in English

Exclusion Criteria:

  • Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol
  • Other non-Black or non-African-American ethnic groups
Male
18 Years and older
No
Contact: Christian Nelson, PhD 646-888-0030
Contact: Andrew Roth, MD 646-888-0024
United States
 
NCT00581672
07-125
Not Provided
Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center
  • University School of Medicine(VA-NYU)
  • State University of New York - Downstate Medical Center
  • Kings County Hospital Center
Principal Investigator: Christian Nelson, PhD Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center
October 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP